Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 21, 2016

MS Treatment Guideline — MS Patient Comments are being requested

  • For the Benefit of the Patient
    /
  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
                                       …
For the Benefit of the Patient

September 20, 2016

Stem Cell Therapy Works Long-Term for MS

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
                                       …
Multiple Sclerosis

September 20, 2016

New Ampyra Trial Bolsters MS Efficacy Claims

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
                                       …
Alternative therapies and devices for Multiple Sclerosis (MS)

September 20, 2016

European MS Guidance Taking Shape – ECTRIMS teases the first-ever MS drug guideline

  • Multiple Sclerosis
    /
                                       …
Multiple Sclerosis

September 20, 2016

Registry Data: Lemtrada More Effective than Competing MS Tx

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
                                       …
MS Drug Therapies

September 20, 2016

Siponimod May Slow Worsening in SPMS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
                                       …
MS Drug Therapies

September 18, 2016

Novartis BAF312 reduced the risk of disability progression in pivotal phase III study in secondary progressive MS patients

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
                                       …
MS Drug Therapies

September 18, 2016

Novartis data finds relapsing MS patients on Gilenya® had greater treatment retention and satisfaction rates vs. injectable DMTs

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
                                       …
MS Drug Therapies

September 15, 2016

Tanner Center and Foundation for MS in Birmingham, AL receives PCORI grant for researching direct rehabilitation services

  • MS Research Study and Reports
    /
                                       …
MS Research Study and Reports

September 14, 2016

PHASE III EFFICACY RESULTS OF INVESTIGATIONAL MEDICINE OCREVUS™ (OCRELIZUMAB) REINFORCED BY EXPLORATORY ANALYSES IN TWO FORMS OF MULTIPLE SCLEROSIS

  • MS Drug Therapies
    /
                                       …
MS Drug Therapies

Categories

Latest Blog Posts